{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:30:02Z","timestamp":1771921802812,"version":"3.50.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Thyroid carcinosarcoma (TCS) is a rare and aggressive malignant tumor, typically reported as a primary thyroid neoplasm. Here, we present an unusual case of TCS occurring in the chest wall. The patient was a 66-year-old woman with a history of papillary thyroid carcinoma (PTC) diagnosed 12 years prior. She received two courses of radioactive iodine (RAI) therapy (200 mCi and 150 mCi) five years ago for metastatic disease in cervical lymph nodes and lungs. Four years after completing RAI treatment, she presented with a progressively enlarging left chest wall mass, which was surgically resected and pathologically confirmed as TCS. This report details the patient\u2019s clinical course and explores the temporal and topographic association between the development of TCS and the prior RAI therapy.<\/jats:p>","DOI":"10.3389\/fonc.2025.1684784","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:26:14Z","timestamp":1768458374000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: A rare case of chest wall thyroid carcinosarcoma"],"prefix":"10.3389","volume":"15","author":[{"given":"Tianyun","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Pathology, The Second Affiliated Hospital of Kunming Medical University","place":["Kunming, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengpeng","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Second Affiliated Hospital of Kunming Medical University","place":["Kunming, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yunnan Maternal and Child Health Hospital","place":["Kunming, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunmei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Second Affiliated Hospital of Kunming Medical University","place":["Kunming, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minmin","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Second Affiliated Hospital of Kunming Medical University","place":["Kunming, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Second Affiliated Hospital of Kunming Medical University","place":["Kunming, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Kui","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Second Affiliated Hospital of Kunming Medical University","place":["Kunming, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Second Affiliated Hospital of Kunming Medical University","place":["Kunming, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13044-018-0055-8","article-title":"A rare Malignant thyroid carcinosarcoma with aggressive behavior and DICER1 gene mutation: a case report with literature review","volume":"11","author":"Yang","year":"2018","journal-title":"Thyroid Res"},{"key":"B2","article-title":"Carcinosarcoma of the thyroid: a case report","volume":"14","author":"Naqiyah","year":"2010","journal-title":"Hippokratia"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-22-0293","article-title":"The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading","volume":"30","author":"Juhlin","year":"2023","journal-title":"Endocrine-related Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"226","DOI":"10.4103\/2278-330X.119928","article-title":"Carcinosarcoma thyroid: An unusual morphology with a review of the literature","volume":"2","author":"Agrawal","year":"2013","journal-title":"South Asian J cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00432-025-06203-z","article-title":"Management strategies for primary lung carcinosarcoma: a case study and comprehensive literature review","volume":"151","author":"Wang","year":"2025","journal-title":"J Cancer Res Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3390\/medicina61071156","article-title":"Carcinosarcoma of the endometrium-pathology, molecular landscape and novel therapeutic approaches","volume":"61","author":"Kostov","year":"2025","journal-title":"Med (Kaunas Lithuania)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3390\/ijms18050911","article-title":"Radiation and thyroid cancer","volume":"18","author":"Albi","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"106694","DOI":"10.1016\/j.oraloncology.2024.106694","article-title":"A rare case of thyroid carcinosarcoma arising from recurrent papillary thyroid cancer: Case report and review of the literature","volume":"150","author":"Gao","year":"2024","journal-title":"Oral Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-0883-1","article-title":"Guidelines for radioiodine therapy of differentiated thyroid cancer","volume":"35","author":"Luster","year":"2008","journal-title":"Eur J Nucl Med Mol imaging"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1515\/reveh.2010.25.1.63","article-title":"Should we be concerned about the rapid increase in CT usage","volume":"25","author":"Brenner","year":"2010","journal-title":"Rev Environ Health"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1530\/EC-25-0116","article-title":"BRAF V600E and TERT promoter mutations and their impact on recurrent papillary thyroid carcinoma progression","volume":"14","author":"Nhung","year":"2025","journal-title":"Endocrine connections"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2020.04.012","article-title":"Histiocytic sarcoma arising from thyroid gland with BRAF V600E mutation","volume":"52","author":"Ge","year":"2020","journal-title":"Pathology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1053\/crad.2000.0599","article-title":"Post-radiation sarcomas: a review of the clinical and imaging features in 63 cases","volume":"56","author":"Sheppard","year":"2001","journal-title":"Clin radiology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05625-4","article-title":"Risk of primary breast cancer in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a systematic review and meta-analysis","volume":"49","author":"Nappi","year":"2022","journal-title":"Eur J Nucl Med Mol imaging"},{"key":"B16","doi-asserted-by":"publisher","first-page":"503797","DOI":"10.1016\/j.mrgentox.2024.503797","article-title":"The effects of iodine 131 treatment on chromosomal and oxidative DNA damage in papillary thyroid carcinoma","volume":"898","author":"Bitgen","year":"2024","journal-title":"Mutat Res Genet Toxicol Environ mutagenesis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/science.1140735","article-title":"An oncogene-induced DNA damage model for cancer development","volume":"319","author":"Halazonetis","year":"2008","journal-title":"Sci (New York NY)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.3190","article-title":"Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer","volume":"309","author":"Xing","year":"2013","journal-title":"Jama"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0047","article-title":"Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation","volume":"65","author":"Knauf","year":"2005","journal-title":"Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6060(97)90127-6","article-title":"Management of thyroid carcinosarcoma","volume":"122","author":"al-Sobhi","year":"1997","journal-title":"Surgery"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85271","article-title":"Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers","volume":"126","author":"Landa","year":"2016","journal-title":"J Clin Invest"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2018.0089","article-title":"NCCN guidelines insights: thyroid carcinoma, version 2.2018","volume":"16","author":"Haddad","year":"2018","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60421-9","article-title":"Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial","volume":"384","author":"Brose","year":"2014","journal-title":"Lancet (London England)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43\u20139006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1684784\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T06:56:12Z","timestamp":1771916172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1684784\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":24,"alternative-id":["10.3389\/fonc.2025.1684784"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1684784","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"article-number":"1684784"}}